ImageneBio officer reports initial share and option holdings
ImageneBio, Inc. principal accounting officer Robert B. Lally filed an initial statement of beneficial ownership, reporting his equity interests in the company.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
3
Rhea-AI Filing Summary
ImageneBio, Inc. principal accounting officer Robert B. Lally filed an initial statement of beneficial ownership, reporting his equity interests in the company. He holds 58,778 shares of common stock, including 56,940 restricted stock units, plus an employee stock option for 25,410 shares at $6.20 per share expiring on March 15, 2036.
Insider Trade Summary
Holdings reported, no transactions
Holdings
Insider
Lally Robert B
Role
Principal Accounting Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Holding | Employee Stock Option (right to buy) | -- | -- | -- |
| Holding | Common Stock | -- | -- | -- |
Holdings:
Employee Stock Option (right to buy) — 25,410 contracts (Direct);
Common Stock — 58,778 shares (Direct)
Footnotes (2)
- F1. Includes 56,940 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. (i) 40,000 shares underlying the RSUs will vest in four equal installments of 25% on each of July, 15, 2026, March 1, 2027, March 1, 2028, and March 1, 2029, and (ii) 16,940 shares underlying the RSUs will vest as to 25% on March 15, 2027, with the remaining RSUs vesting in successive equal quarterly installments on each of the next 12 Standard Quarterly Dates thereafter, in each case, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2025 Equity Incentive Plan (the "2025 Plan")) through each such vesting date. The "Standard Quarterly Dates" are each of March 15, June 15, September 15 and December 15.
- F2. This option vests over four years, with 25% of the shares subject to this option vesting on March 15, 2027, and the remaining shares vesting in 36 substantially equal monthly installments thereafter, subject to the Reporting Person's Continuous Service (as defined in the 2025 Plan) through each such vesting date.
Key Figures
Common stock holdings: 58,778 shares
Restricted stock units: 56,940 RSUs
RSUs main tranche: 40,000 RSUs
+5 more
8 metrics
Common stock holdings
58,778 shares
Total common stock reported following the Form 3
Restricted stock units
56,940 RSUs
Each RSU represents one share of common stock upon settlement
RSUs main tranche
40,000 RSUs
Vest in four 25% installments from July 15, 2026 to March 1, 2029
RSUs secondary tranche
16,940 RSUs
Vest 25% on March 15, 2027, then in 12 equal quarterly installments
Option underlying shares
25,410 shares
Employee stock option over common stock
Option exercise price
$6.20 per share
Exercise price for the employee stock option
Option expiration
March 15, 2036
Expiration date of the employee stock option
Initial option vesting
25% on March 15, 2027
First vesting date for the option; remainder monthly thereafter
Key Terms
restricted stock units ("RSUs"), Employee Stock Option (right to buy), Continuous Service, 2025 Equity Incentive Plan, +1 more
5 terms
restricted stock units ("RSUs") financial
"Includes 56,940 restricted stock units ("RSUs"). Each RSU represents a contingent right..."
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
Employee Stock Option (right to buy) financial
"security_title": "Employee Stock Option (right to buy)""
Continuous Service financial
"subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2025 Equity Incentive Plan..."
2025 Equity Incentive Plan financial
"as defined in the Issuer's 2025 Equity Incentive Plan (the "2025 Plan")"
Standard Quarterly Dates financial
"The "Standard Quarterly Dates" are each of March 15, June 15, September 15 and December 15."
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the ImageneBio (IMA) Form 3 filing by Robert B. Lally show?
The Form 3 shows Robert B. Lally’s existing equity holdings in ImageneBio, Inc., including common stock, restricted stock units, and stock options. It is an initial ownership report rather than a new purchase or sale, providing transparency into his current stake and incentives.
What restricted stock unit (RSU) awards are disclosed for ImageneBio (IMA) officer Lally?
The filing discloses 56,940 restricted stock units for Robert B. Lally. Of these, 40,000 RSUs vest in four 25% installments between July 15, 2026 and March 1, 2029, while 16,940 RSUs vest quarterly starting March 15, 2027, all subject to continuous service.
What stock options does Robert B. Lally hold in ImageneBio (IMA)?
He holds an employee stock option covering 25,410 shares of ImageneBio common stock at an exercise price of $6.20 per share. The option expires on March 15, 2036 and vests over four years, beginning with 25% vesting on March 15, 2027.
How do the RSUs for ImageneBio (IMA) vest for Robert B. Lally?
For 40,000 RSUs, vesting occurs in four equal 25% installments on July 15, 2026, March 1, 2027, March 1, 2028, and March 1, 2029. The remaining 16,940 RSUs vest 25% on March 15, 2027 and then in equal quarterly installments on Standard Quarterly Dates.
What conditions affect vesting of ImageneBio (IMA) equity awards for Lally?
Both the RSUs and stock option are subject to Robert B. Lally’s “Continuous Service” under ImageneBio’s 2025 Equity Incentive Plan. This means vesting only occurs if he remains in qualifying service through each specified vesting date outlined in the award schedules.
AI-generated analysis. How Rhea-AI works. Not financial advice.
